Bengaluru] Drugmaker Pfizer has sold its entire stake in Haleon for about US$3.24 billion to institutional investors and the ...

according to GSK. At the same time, antimicrobial resistance (AMR) to common drugs used to treat these infections is on the rise, leading to treatment failure, with a Singapore study published ...

8-10 Dr Lee Tau Hong, Infectious Disease Specialist, Infectious Diseases Care Clinic in Singapore, shared with GSK, "RSV poses a significant burden on patients, families, and healthcare systems ...

GSK Plc is a long-term underperformer among Europe’s Big Pharma stocks. And with key drug patents set to expire and vaccine sales falling, some market participants say it may draw in activist ...

GSK, Pfizer, Sanofi, MSD, Novartis, and Roche among AbbVie’s neighbours. “We are grateful for AbbVie’s continued trust in the strength of Singapore’s biopharmaceutical manufacturing ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

GSK PLC GSK shares rose 1.64% to £14.53 Monday, on what proved to be an all-around mediocre trading session for the stock market, with the FTSE 100 Index UKX holding steady at 8,658.98.

GSK (NYSE:GSK) shares rose for seven straight sessions, as the stock ended 0.7% higher at $40.32 on Monday. The pharmaceutical giant gained over 6.5% in the preceding six sessions. The stock has ...